Warby Parker saw the highest growth of 0.49% in patent filings in June and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Warby Parker‘s patent filings and grants. Buy the databook here.
Warby Parker has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with two publications in Q2 2024
The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 67% of filings. The World Intellectual Property Organization(WIPO), European Patent Office(EPO), Canada(CA), and Israel(IL) patent Office are among the top ten patent offices where Warby Parker is filings its patents. Among the top granted patent authorities, Warby Parker has 50% of its grants in Canada(CA) and 50% in Israel(IL).
NEC could be the strongest competitor for Warby Parker
Patents related to healthtech and digitalization lead Warby Parker's portfolio
Warby Parker has the highest number of patents in healthtech followed by, digitalization and ecommerce. For healthtech, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Ophthalmic devices related patents lead Warby Parker portfolio followed by image management, and active and passive safety
Warby Parker has highest number of patents in ophthalmic devices followed by image management, active and passive safety, online retail, and e-commerce. For ophthalmic devices, nearly 33% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of Warby Parker's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.